Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Charles L . Loprinzi, M.D.

Back to Research Profile

  1. Loprinzi CL, Qin R, Baclueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN. Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1. J Clin Oncol 2009 Nov 09. [Epub ahead of print]
    View PubMed
  2. Loprinzi CL, Sloan JA, Novotny P. Letter to the Editor. Menopause 2009 Oct 02. [Epub ahead of print]
    View PubMed
  3. Hines SL, Mincey B, Dentchev T, Sloan JA, Perez EA, Johnson DB, Schaefer PL, Alberts S, Liu H, Kahanic S, Mazurczak MA, Nikcevich DA, Loprinzi CL. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Res Treat 2009 Oct; 117(3):603-9. Epub 2009 Feb 12.
    View PubMed
  4. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, Brandt KR, Pruthi S, Chute CG, Olson JE, Couch FJ, Ingle JN, Goetz MP. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009 Sep 1; 27(25):4082-8. Epub 2009 Jul 27.
    View PubMed
  5. Loprinzi CL, Diekmann B, Novotny PJ, Stearns V, Sloan JA. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause 2009 Sep-Oct; 16(5):883-7.
    View PubMed
  6. Loprinzi CL, Diekmann B, Novotny PJ, Stearns V, Sloan JA. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause 2009 Sep-Oct; 16(5):883-7.
    View PubMed
  7. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer 2009 Aug 07. [Epub ahead of print]
    View PubMed
  8. Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 2009 Jun 10; 27(17):2831-7. Epub 2009 Mar 30.
    View PubMed
  9. Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland KM Jr, Fuloria J, Flynn PJ, Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer 2009 May 27. [Epub ahead of print]
    View PubMed
  10. Loprinzi CL, Barton DL. On hot flash mechanism, measurement, and treatment. Menopause 2009 May 08. [Epub ahead of print]
    View PubMed
  11. Barton DL, Soori GS, Bauer BA, Sloan JA, Johnson PA, Figueras C, Duane S, Mattar B, Liu H, Atherton PJ, Christensen B, Loprinzi CL. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 2009 May 06. [Epub ahead of print]
    View PubMed
  12. Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause 2009 May-Jun; 16(3):477-83.
    View PubMed
  13. Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden Iii Jd, Liu H, Schaefer PL, Marchello BT, Christensen BJ, Loprinzi CL. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer 2009 Apr; 17(4):451-60. Epub 2009 Jan 13.
    View PubMed
  14. Loprinzi CL, Diekmann B, Novotny PJ, Stearns V, Sloan JA. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause 2009 Mar 17. [Epub ahead of print]
    View PubMed
  15. Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA. Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol 2009 Mar 1; 27(7):1047-53. Epub 2008 Dec 15.
    View PubMed
  16. Loprinzi CL, Dueck AC, Khoyratty BS, Barton DL, Jafar S, Rowland KM Jr, Atherton PJ, Marsa GW, Knutson WH, Bearden JD 3rd, Kottschade L, Fitch TR. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 2009 Mar; 20(3):542-9. Epub 2009 Jan 06.
    View PubMed
  17. Dronca RS, Loprinzi CL, Hartmann LC. Breast cancer risk reduction: SERMs, surgery, and beyong Menopausal Management 2009 Mar/Apr; 18(2):14-22.
    View PubMed
  18. Barton DL, Loprinzi CL. Does hormonal therapy decrease tamoxifen associated hot flashes? Breast Cancer Res Treat 2009 Feb 10. [Epub ahead of print]
    View PubMed
  19. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, Levine TR, Rex DK, Ahnen D, Knigge KL, Lance P, Jiang X, Smith DI, Ahlquist DA. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 2009 Feb; 136(2):459-70. Epub 2008 Oct 15.
    View PubMed
  20. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Wolf S. Newer antidepressants for hot flashes--should their efficacy still be up for debate? Menopause 2009 Jan-Feb; 16(1):184-7.
    View PubMed
  21. Loprinzi CL, SLoan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T, Barton D, Novotny P. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 2009; 27(17):2831-37 Epub 0.
    View PubMed
  22. Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer 2008 Oct 15; 113(8):2205-14.
    View PubMed
  23. Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer 2008 Oct 15; 113(8):2205-14.
    View PubMed
  24. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008 Oct 7; 149(7):441-50, W81.
    View PubMed
  25. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008 Oct 7; 149(7):441-50, W81.
    View PubMed
  26. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol 2008 Oct; 9(10):993-1001.
    View PubMed
  27. Grothey A, Adjei AA, Alberts SR, Perez EA, Jaeckle KA, Loprinzi CL, Sargent DJ, Sloan JA, Buckner JC, North Central Cancer Treatment Group. North Central Cancer Treatment Group--achievements and perspectives. Semin Oncol 2008 Oct; 35(5):530-44.
    View PubMed
  28. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer 2008 Aug 15; 113(4):847-53.
    View PubMed
  29. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause 2008 Jul-Aug; 15(4 Pt 1):655-60.
    View PubMed
  30. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 2008 Jul; 44(11):1507-15. Epub 2008 Jun 18.
    View PubMed
  31. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008 Jun 15; 112(12):2802-8.
    View PubMed
  32. Loprinzi CL, Barton DL, Carns PE. Stellate-ganglion block: a new treatment for hot flushes? Lancet Oncol 2008 Jun; 9(6):506-7.
    View PubMed
  33. Loprinzi CL, Kalemkerian GP. The physician on the horns of a dilemma. J Clin Oncol 2008 May 1; 26(13):2221-2.
    View PubMed
  34. Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL. Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer 2008 Jan; 16(1):75-82. Epub 2007 Jun 28.
    View PubMed
  35. Bleicher J, Bhaskara A, Huyck T, Constantino S, Bardia A, Loprinzi CL, Silberstein PT. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials. J Support Oncol 2008 Jan; 6(1):27-32.
    View PubMed
  36. Loprinzi CL, Kalemkerian GP. The phyisican on the horns of dilemma. J Clin Oncol 2008; 26(13):2221-22.
    View PubMed
  37. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer 2008; 112(12):2802-8.
    View PubMed
  38. Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL. Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer 2008; 16:75-82.
    View PubMed
  39. Grothey A, Adjei AA, Alberts SR, Perez EA, Jaeckle KA, Loprinzi CL, Sargent DJ, Sloan JA, Buckner JC for the North Central Cancer Treatment Group. North Central Cancer Treatment Group--Achievements and Perspectives. Seminars in Oncology 2008; 35(5):530-44.
    View PubMed
  40. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY, North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007 Nov 1; 110(9):2110-8.
    View PubMed
  41. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY, North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007 Nov 1; 110(9):2110-8.
    View PubMed
  42. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy - A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3). Cancer 2007 Nov 1; 110(9):2110-8.
    View PubMed
  43. Loprinzi CL, Maddocks-Christianson K, Wolf SL, Rao RD, Dyck PJ, Mantyh P, Dyck PJ. The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J 2007 Nov-Dec; 13(6):399-403.
    View PubMed
  44. Loprinzi CL, Maddocks-Christianson K, Wolf SL, Rao RD, Dyck PJ, Mantyh P, Dyck PJ. The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J 2007 Nov-Dec; 13(6):399-403.
    View PubMed
  45. Clark MM, Vickers KS, Hathaway JC, Smith M, Looker SA, Petersen LR, Pinto BM, Rummans TA, Loprinzi CL. Physical activity in patients with advanced-stage cancer actively receiving chemotherapy. J Support Oncol 2007 Nov-Dec; 5(10):487-93.
    View PubMed
  46. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer 2007 Sep 15; 110(6):1396-403.
    View PubMed
  47. Barton DL, Loprinzi CL, Atherton P, Raymond J, Shanafelt T, Hines S, Palmieri F, Rummans T, Adjei AA, Sloan J. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. Support Cancer Ther 2007 Sep 1; 4(4):219-24.
    View PubMed
  48. Kottschade L, Loprinzi C, Rao R. Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trial. Support Cancer Ther 2007 Sep 1; 4(4):251-3.
    View PubMed
  49. Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL. Pilot evaluation of flaxseed for the management of hot flashes. J Soc Integr Oncol 2007 Summer; 5(3):106-12.
    View PubMed
  50. Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst 2007 May 2; 99(9):672-9.
    View PubMed
  51. Perez DG, Zahasky KM, Loprinzi CL, Sloan J, Novotny P, Barton D, Pritchard KI. Tamoxifen-associated hot flashes in women. Support Cancer Ther 2007 May 1; 4(3):152-6.
    View PubMed
  52. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007 Apr 1; 67(5):1318-22.
    View PubMed
  53. Sood A, Barton DL, Bauer BA, Loprinzi CL. A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther 2007 Mar; 6(1):8-13.
    View PubMed
  54. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol 2007 Mar; 5(3):119-25, 128.
    View PubMed
  55. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol 2007 Mar; 5(3):119-125.
  56. Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, Rowland KM, Bernath A, Loots ML, Le-Lindqwister NA, Tschetter LK, Garneau SC, Flynn KA, Ebbert LP, Wender DB, Loprinzi CL. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc 2007 Feb; 82(2):186-95.
    View PubMed
  57. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. Clin Ther 2007 Feb; 29(2):230-41.
    View PubMed
  58. Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA, Balcueva EP, Burger KN, Novotny PJ, Carlson MD, Duane SF, Corso SW, Johnson DB, Jaslowski AJ. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 2007 Jan 20; 25(3):308-12.
    View PubMed
  59. Vincent A, Barton DL, Mandrekar JN, Cha SS, Zais T, Wahner-Roedler DL, Keppler MA, Kreitzer MJ, Loprinzi C. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause 2007 Jan-Feb; 14(1):45-52.
    View PubMed
  60. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Lutteh LA, Wong GY, North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007; 110(9):2110-8.
    View PubMed
  61. Clark MM, Vickers VS, Hathaway JC, Smith M, Looker SA, Petersen LR, Pinto BM, Rummans TA, Loprinzi CL. Physical activity in patients with advanced-stage cancer actively receiving chemotherapy. J Support Oncol 2007; 5(10):487-93.
    View PubMed
  62. Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL. Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer 2007(Epub ahead of print).
    View PubMed
  63. Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL. Pilot Evaluation of Flaxseed for the Managment of Hot Flashes. J Soc for Integrative Oncology 2007; 5(3):106-112.
    View PubMed
  64. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clinical Therapeutics 2007; 29(2):230-41.
  65. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006 Fall; 4(4):143-52.
    View PubMed
  66. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006 Fall; 4(4):143-52.
    View PubMed
  67. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006 Fall; 4(4):143-52.
    View PubMed
  68. Markovic SN, Suman VJ, Ingle JN, Kaur JS, Pitot HC, Loprinzi CL, Rao RD, Creagan ET, Pittelkow MR, Allred JB, Nevala WK, Celis E. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization. Am J Clin Oncol 2006 Aug; 29(4):352-60.
    View PubMed
  69. Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial. Am J Ther 2006 Jul-Aug; 13(4):291-7.
    View PubMed
  70. Clark MM, Hurt RD, Croghan IT, Patten CA, Novotny P, Sloan JA, Dakhil SR, Croghan GA, Wos EJ, Rowland KM, Bernath A, Morton RF, Thomas SP, Tschetter LK, Garneau S, Stella PJ, Ebbert LP, Wender DB, Loprinzi CL. The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav 2006 Jul; 31(7):1144-52. Epub 2005 Aug 30.
    View PubMed
  71. Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006 Jun 20; 24(18):2836-41.
    View PubMed
  72. Sideras K, Schaefer PL, Okuno SH, Sloan JA, Kutteh L, Fitch TR, Dakhil SR, Levitt R, Alberts SR, Morton RF, Rowland KM, Novotny PJ, Loprinzi CL. Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc 2006 Jun; 81(6):758-67.
    View PubMed
  73. Perez DG, Loprinzi CL, Sloan J, Novotny P, Barton D, Carpenter L, Smith D, Christensen B, Rummans T. Pilot evaluation of bupropion for the treatment of hot flashes. J Palliat Med 2006 Jun; 9(3):631-7.
    View PubMed
  74. Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD 3rd, Mailliard JA, Tschetter LK, Fitch TR, Kugler JW. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol 2006 Mar 20; 24(9):1409-14. Epub 2006 Feb 27.
    View PubMed
  75. Steensma DP, Molina R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KM Jr, Dentchev T, Novotny PJ, Tschetter LK, Alberts SR, Hogan TF, Law A, Loprinzi CL. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol 2006 Mar 1; 24(7):1079-89.
    View PubMed
  76. Carlson RW, Brown E, Burstein HJ, Gradishar WJ, Hudis CA, Loprinzi C, Mamounas EP, Perez EA, Pritchard K, Ravdin P, Recht A, Somlo G, Theriault RL, Winer EP, Wolff AC, National Comprehensive Cancer Network. NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw 2006 Mar; 4 Suppl 1:S1-26.
    View PubMed
  77. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care 2006 Jan-Feb; 23(1):35-40.
    View PubMed
  78. Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J. Dehydroepiandrosterone for the treatment of hot flashes: A pilot study. Support Cancer Ther 2006; 3(2):91-7.
  79. Loprinzi CL. Antidepressants and gabapentin. Menopause Management 2006; 15(suppl 1):29-32.
  80. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006; 4(4):143-52.
    View PubMed
  81. Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christensen B, Collins M, Loprinzi CL. Pilot evaluation of aprepitant for the treatment of hot flashes. Supportive Cancer Therapy 2006; 3(4):240-6.
    View PubMed
  82. Perez EA, Suman VJ, Rowland KM, Ingle JN, Salim M, Loprinzi CL, Flynn PJ, Mailliard JA, Kardinal CG, Krook JE, Thrower AR, Visscher DW, Jenkins RB. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer 2006; 6(5):425-32.
  83. Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christenson B, Collins M, Loprinzi C. Pilot evaluation of aprepitant for the treatment of hot flashes. Supp Cancer Ther 2006; 3(4):240-6.
  84. Loprinzi CL, Stearns V, Barton D. Centrally active nonhormonal hot flash therapies. Am J Med 2005 Dec 19; 118(12 Suppl 2):118-23.
    View PubMed
  85. Perez EA, Suman VJ, Rowland KM, Ingle JN, Salim M, Loprinzi CL, Flynn PJ, Mailliard JA, Kardinal CG, Krook JE, Thrower AR, Visscher DW, Jenkins RB. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer 2005 Dec; 6(5):425-32.
    View PubMed
  86. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol 2005 Nov 20; 23(33):8512-19.
    View PubMed
  87. Loprinzi CL, Flynn PJ, Carpenter LA, Atherton P, Barton DL, Shanafelt TD, Rummans TA, Sloan JA, Adjei AA, Mincey BA, Fitch TR, Collins M. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005 Oct; 8(5):924-30.
    View PubMed
  88. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF, Krook JE, Rowland KM, Mazurczak MA, Berg AR, Kim GP. Evaluation of shark cartilage in patients with advanced cancer - A North Central Cancer Treatment Group trial. Cancer 2005 Jul 1; 104(1):176-82.
    View PubMed
  89. Vickers KS, Hathaway JC, Patten CA, Clark MM, Britt TL, Looker SA, Johnson PT, Loprinzi CL. Cancer patients' and patient advocates' perspectives on a novel information source: a qualitative study of the art of oncology, when the tumor is not the target. J Clin Oncol 2005 Jun 20; 23(18):4013-20.
    View PubMed
  90. Ryan M, Moynihan TJ, Loprinzi CL. As-needed morphine: yes, but at what dose and at what interval? J Clin Oncol 2005 Jun 1; 23(16):3849-52.
    View PubMed
  91. Adelson KB, Loprinzi CL, Hershman DL. Treatment of hot flushes in breast and prostate cancer. Expert Opin Pharmacother 2005 Jun; 6(7):1095-106.
    View PubMed
  92. Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 2005 Apr 20; 23(12):2606-17.
    View PubMed
  93. Loprinzi CL, Moynihan TJ. Mastering the art of oncology. Minn Med 2005 Apr; 88(4):34-5, 54.
    View PubMed
  94. Whelan TJ, Loprinzi C. Physician/patient decision aids for adjuvant therapy. J Clin Oncol 2005 Mar 10; 23(8):1627-30.
    View PubMed
  95. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience. Cancer 2005 Feb 15; 103(4):863-8.
    View PubMed
  96. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf 2005; 28(5):401-16.
    View PubMed
  97. Molina JR, Barton DL, Loprinzi CL. Management of chemotherapy-induced ovarian failure. Drug Safey 2005; 28(5):401-416.
  98. Loprinzi CL, Moynihan TJ. Discussing your chemotherapy treatment options with your doctor. Coping 2005:20-3.
  99. Perez DG, Loprinzi CL. Newer antidepressants and other nonhormonal agents for the treatment of hot flashes. Compr Ther 2005; 31(3):224-36.
    View PubMed
  100. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer 2004 Dec; 12(12):859-63.
    View PubMed
  101. Loprinzi CL, Barton DL, Carpenter LA, Sloan JA, Novotny PJ, Gettman MT, Christensen BJ. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc 2004 Oct; 79(10):1247-51.
    View PubMed
  102. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer 2004 Sep; 12(9):640-4.
    View PubMed
  103. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer 2004 Jul 24; Epub ahead of print.
  104. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004 Jun 15; 22(12):2469-76.
    View PubMed
  105. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Seitz JF, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 2004 May 15; 22(10):1797-806.
    View PubMed
  106. Shanafelt TD, Loprinzi C, Marks R, Novotny P, Sloan J. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? J Clin Oncol 2004 May 15; 22(10):1966-74.
    View PubMed
  107. Barton D, Wilwerding M, Carpenter L, Loprinzi C. Libido as part of sexuality in female cancer survivors. Oncol Nurs Forum 2004 May; 31(3):599-609.
    View PubMed
  108. Perez DG, Loprinzi CL, Barton DL, Pockaj BA, Sloan J, Novotny PJ, Christensen BJ. Pilot evaluation of mirtazapine for the treatment of hot flashes. The Journal of Supportive Oncology 2004 Jan-Feb; 2(1):50-6.
    View PubMed
  109. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang HY, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004; 22(4):515-21.
    View PubMed
  110. Barton D, Loprinzi C. Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clin J Oncol Nurs 2004; 8(1):39-42.
    View PubMed
  111. Hobday TJ, Loprinzi CL. Review of manuscript “Selecting Adjuvant Endocrine Therapy for Breast Cancer”. Oncology 2004; 18(14):1744-45.
  112. Okuno SH, Foote RL, Olmscheid MA, Sloan JA, Sapiente RA, Novotny PJ, Anthes ML, Loprinzi CL. Evaluation of an oral capsaicin lozenge for preventing radiation-induced mucositis. Journal of Cancer Integrative Medicine 2004; 2(4):179-83.
  113. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol2003 Nov-Dec; 1(4):274-8.
    View PubMed
  114. Hoda D, Perez DG, Loprinzi CL. Hot flashes in breast cancer survivors. Breast J 2003 Sep-Oct; 9(5):431-8.
    View PubMed
  115. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Research & Treatment 2003 Jul; 80(1):99-104.
    View PubMed
  116. Loprinzi C, Rajkumar SV. Why not start with thalidomide? J Clin Oncol 2003 Jun 1; 21(11):2211-4.
    View PubMed
  117. Loprinzi CL, Hayes D, Smith T. Doc, shouldn't we be getting some tests? J Clin Oncol 2003 May 1; 21(9 Suppl):108s-111s.
    View PubMed
  118. Loprinzi CL, Johnson ME, Steer G. Doc, how much time do I have? J Clin Oncol 2003 May 1; 21(9 Suppl):5s-7s.
    View PubMed
  119. Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler DL, Rummans TA, Christensen B, Dakhill SR, Martin LS. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol 2003 May/Jun; 1(1):47-51.
    View PubMed
  120. Loprinzi CL, Ravdin PM. Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physicians. J Natl Compr Canc Netw 2003 Apr; 1(2):189-96.
    View PubMed
  121. Croghan GA, Sloan JA, Croghan IT, Novotny P, Hurt RD, DeKrey WL, Mailliard JA, Ebbert LP, Swan DK, Walsh DJ, Wiesenfeld M, Levitt R, Stella P, Johnson PA, Tschetter LK, Loprinzi C. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob Res 2003 Apr; 5(2):181-7.
    View PubMed
  122. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003 Mar 6; 348(10):883-90.
    View PubMed
  123. Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, Kardinal CG, Knost JA, Tirona MT, Addo F, Morton RF, Michalak JC, Schaefer PL, Porter PA, Stella PJ. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol 2003 Mar 1; 21(5):914-20.
    View PubMed
  124. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: Symptom management for prostate cancer patients treated with hormonal ablation. Oncologist 2003; 8(5):474-87.
    View PubMed
  125. Barton DL, Loprinzi CL, Gostout B. Management of menopausal symptoms in cancer patients. Menopause Digest 2003; 15(2):26-7.
  126. Jatoi A, Loprinzi CL. The cancer anorexia/weight loss syndrome-a review of therapeutic strategies. Business Briefing:European PharmacoTherapy 2003;102-4.
  127. Loprinzi CL, Ravdin PM. Decision-making for patients with early breast cancer: individualized decisions for and by patients and their physicians. JNCCN 2003; 1(2):189-96.
  128. Stearns V, Loprinzi CL. New therapeutic approaches for hot flashes. Journal of Supportive Oncology 2003; 1(1):11-21.
    View PubMed
  129. Barton D, Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clinical Breast Cancer 2002 Dec; 3 Suppl 3:S121-7.
    View PubMed
  130. Barton D, Loprinzi C, Quella S, Sloan J, Pruthi S, Novotny P. Depomedroxyprogesterone acetate for hot flashes. J Pain Symptom Manage 2002 Dec; 24(6):603-7.
    View PubMed
  131. Loprinzi CL, Barton DL, Sloan JA, Zahasky KM, Smith DR, Pruthi S, Novotny PJ, Perez EA, Christensen BJ. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002 Nov; 77(11):1159-63.
    View PubMed
  132. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002 Nov; 77(11):1207-18.
    View PubMed
  133. Thome SD, Loprinzi CL, Heldebrant MP. Determination of potential adjuvant systemic therapy benefits for patients with resected cutaneous melanomas. Mayo Clin Proc 2002 Sep; 77(9):913-7.
    View PubMed
  134. Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT, Rowland KM, Stella PJ, Johnson JA. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 2002 Jul; 98(1-2):195-203.
    View PubMed
  135. Loprinzi CL, Barton DL, Rhodes DJ, Wahner-Roedler DL. Newer antidepressants for hot flashes. Patient Care 2002 Jul; 36(9):45-6, 49-51.
  136. Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, Novotny PJ, Poon MA, O'Connell MJ, Loprinzi CL. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 2002 Mar 15; 20(6):1491-8.
    View PubMed
  137. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002 Mar 15; 20(6):1578-83.
    View PubMed
  138. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group Study. J Clin Oncol 2002 Jan 15; 20(2):567-73.
    View PubMed
  139. Barton DL, Loprinzi C, Gostout B. Current management of menopausal symptoms in cancer patients. Oncology (Huntington) 2002 Jan; 16(1):67-74.
    View PubMed
  140. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer 2002 Jan; 10(1):71-5.
    View PubMed
  141. Barton D, La VB, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 2002 Jan-Feb; 29(1):33-40.
    View PubMed
  142. Barton D, LaVasseur B, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 2002 Jan-Feb; 29(1):33-40.
    View PubMed
  143. Barton DL, Loprinzi CL, Ko MG. Managing hot flashes: The truth about the alternatives to traditional hormone replacement therapy. Menopause Manage 2002;11(3):15-19.
  144. Barton D, Loprinzi CL. Novel approaches to preventing chemotherapy-induced cognitive dysfunction: The art of the possible. J Pain Symptom Manage 2002; 24(6):603-7.
    View PubMed
  145. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001 Dec 1; 19(23):4280-90.
    View PubMed
  146. Loprinzi CL, Barton DL, Rhodes DJ, Wahner-Roedler DL. Newer antidepressants for hot flashes. Contemp Ob Gyn 2001 Nov; 46(11):61-2, 64, 67 passim.
  147. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: A critical review of the literature. J Nutr 2001 Nov; 131(11 Suppl S):3095S-108S.
    View PubMed
  148. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer 2001 Aug 1; 92(3):629-33.
    View PubMed
  149. Sloan JA, Loprinzi CL, Laurine JA, Novotny PJ, Vargas-Chanes D, Krook JE, O'Connell MJ, Kugler JW, Tirona MT, Kardinal CG, Wiesenfeld M, Tschetter LK, Hatfield AK, Schaefer PL. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol 2001 Aug 1; 19(15):3539-46.
    View PubMed
  150. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care 2001 May; 4(3):179-82.
    View PubMed
  151. Loprinzi CL, Barton DL, Rhodes D. Management of hot flashes in breast-cancer survivors. Lancet Oncology 2001 Apr; 2(4):199-204.
    View PubMed
  152. Jatoi A, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology (Huntington NY) 2001 Apr; 15(4):497-509.
    View PubMed
  153. Loprinzi CL, Thome SD. Understanding the utility of adjuvant systemic therapy for primary breast cancer. J Clin Oncol 2001 Feb 15; 19(4):972-9.
    View PubMed
  154. Loprinzi CL. Clonidine was effective for reducing tamoxifen-associated hot flashes in postmenopausal women with breast cancer... commentary on Pandya KJ, Raubertas RF, Flynn PJ et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program Study. ANN INTERN MED 2000 May 16;132:788-93. ACP J Club 2001 Jan-Feb; 134(1):24.
  155. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh S, Pfeifle DM, Wender DB, Burch OA. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. J Clin Oncol (Classic Papers and Current Comments) 2001; 92(3):139-43.
  156. Barton D, Loprinzi C, Wahner-Roedler D. Hot flashes - aetiology and management. Drugs Aging 2001; 18(8):597-606.
    View PubMed
  157. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000 Dec 16; 356(9247):2059-63.
    View PubMed
  158. Benson AB 3rd, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Smith TJ, Somerfield MR. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000 Oct 15; 18(20):3586-8.
    View PubMed
  159. Schapira L, Eisenberg PD, MacDonald N, Mumber MP, Loprinzi C. A revisitation of "Doc, how much time do I have?". J Clin Oncol 2000 Jul; 18(13):2640-3.
    View PubMed
  160. Loprinzi CL, Hayes D, Smith T. Doc, shouldn't we be getting some tests? J Clin Oncol 2000 Jun; 18(11):2345-8.
    View PubMed
  161. Sloan JA, Novotny PJ, Loprinzi CL. Design and analysis of cancer control studies using the SAS system. SUGI 25 Proceedings 2000 April 9-12:259-25.
  162. Loprinzi CL, Zahasky KM, Sloan JA, Novotny PJ, Quella SK. Tamoxifen-induced hot flashes. Clinical Breast Cancer 2000 Apr; 1(1):52-6.
    View PubMed
  163. Loprinzi CL, Alberts SR, Christensen BJ, Hanson LJ, Farley DR, Broers JK, Betcher DL, Grady RE, Southorn PA, Johnson TM, Perez EA. History of the development of antiemetic guidelines at Mayo Clinic Rochester. Mayo Clin Proc 2000 Mar; 75(3):303-9.
    View PubMed
  164. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol 2000 Mar; 18(5):1068-74.
    View PubMed
  165. Loprinzi CL, Johnson ME, Steer G. Doc, how much time do I have? J Clin Oncol 2000 Feb; 18(3):699-701.
    View PubMed
  166. Sloan JA, Loprinzi CL, Novotny PJ, Okuno S, Nair S, Barton DL. Sex differences in fluorouracil-induced stomatitis. J Clin Oncol 2000 Jan; 18(2):412-20.
    View PubMed
  167. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr, Camoriano JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999 Oct; 17(10):3299-306.
    View PubMed
  168. Jatoi A, Loprinzi CL. Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am 1999 Oct; 79(5):1145-56.
    View PubMed
  169. Bretscher M, Rummans T, Sloan J, Kaur J, Bartlett A, Borkenhagen L, Loprinzi C. Quality of life in hospice patients. A pilot study. Psychosomatics 1999 Jul-Aug; 40(4):309-13.
    View PubMed
  170. Ingle JN, Suman VJ, Johnson PA, Krook JE, Mailliard JA, Wheeler RH, Loprinzi CL, Perez EA, Jordan VC, Dowsett M. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Clin Cancer Res 1999 Jul; 5(7):1642-9.
    View PubMed
  171. Quella SK, Loprinzi CL, Sloan J, Novotny P, Perez EA, Burch PA, Antolak SJ Jr, Pisansky TM. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 1999 Jul; 162(1):98-102.
    View PubMed
  172. Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA, LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert LP, Tirona MR, Michalak JC, Pierson N. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol 1999 Jun; 22(3):258-61.
    View PubMed
  173. Desch CE, Benson AB 3rd, Smith TJ, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Somerfield MR. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999 Apr; 17(4):1312.
    View PubMed
  174. Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer 1999 Mar 15; 85(6):1284-92.
    View PubMed
  175. Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Research & Treatment 1999 Mar; 54(2):117-22.
    View PubMed
  176. Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 1999 Feb 4; 340(5):346-50.
    View PubMed
  177. Goldberg RM, Loprinzi CL. Cancer anorexia/cachexia. Cancer Treatment & Research 1999; 100:31-41.
    View PubMed
  178. Loprinzi CL, Johnston PB, Sloan JA, Novotny P, Ellison N. Have medical oncologists recently modified surveillance testing patterns for melanoma and/or breast cancer survivors? Cancer Research, Therapy & Control 1999; 9(3-4):205-14.
  179. Okuno SH, Kozelsky T, Loprinzi CL, Nair S. Alleviation of gastrointestinal mucosal toxicity related to chemotherapy and radiation therapy: the NCCTG experience. Cancer Research, Therapy & Control 1999; 9(3-4):193-6.
  180. Loprinzi CL. A flash on hot flashes. J Clin Oncol (Classic Papers and Current Comments) 1999; 4(2):348-9.
  181. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol (Classic Papers and Current Comments) 1999; 4(2):328-32.
  182. Loprinzi CL, Kuross SA, O'Fallon JR, Gesme DH, Gerstner JB, Rospond RM, Cobau CD, Goldberg RM. Randomized, placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol (Classic Papers and Current Comments) 1999; 3(2):514-9.
  183. Finck G, Barton DL, Loprinzi CL, Quella SK, Sloan JA. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage 1998 Nov; 16(5):327-33.
    View PubMed
  184. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O'Fallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 1998 Nov; 16(11):3662-73.
    View PubMed
  185. Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, Novotny PJ, Rummans TA, Dumesic DA, Perez EA. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998 Jul; 16(7):2377-81.
    View PubMed
  186. Quella SK, Loprinzi CL, Sloan JA, Vaught NL, DeKrey WL, Fischer T, Finck G, Pierson N, Pisansky T. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer 1998 May 1; 82(9):1784-8.
    View PubMed
  187. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998 Feb; 16(2):495-500.
    View PubMed
  188. Pritchard K, Loprinzi CL. Estrogen/hormone replacement therapy (ERT/HRT) in women with a previous diagnosis of breast cancer: is it safe and are there alternatives? ASCO Fall Educational Book 1998:81-6.
  189. Sloan JA, Novotny PJ, Loprinzi CL. Analyzing quality of life data via the SAS system. SUGI 1998; 23:1213-22.
  190. Perez EA, Loprinzi CL, Sloan JA, Owens DT, Novotny PJ, Bonner JA. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer 1997 Aug 15; 80(4):676-80.
    View PubMed
  191. Ellison N, Loprinzi CL, Kugler J, Hatfield AK, Miser A, Sloan JA, Wender DB, Rowland KM, Molina R, Cascino TL, Vukov AM, Dhaliwal HS, Ghosh C. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol 1997 Aug; 15(8):2974-80.
    View PubMed
  192. Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer 1997 Jul 15; 80(2):218-24.
    View PubMed
  193. Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O'Fallon JR, Erlichman C, O'Connell MJ, Laurie JA. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology 1997 Jul-Aug; 54(4):287-92.
    View PubMed
  194. Okuno SH, Foote RL, Loprinzi CL, Gulavita S, Sloan JA, Earle J, Novotny PJ, Burk M, Frank AR. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 1997 Jun 1; 79(11):2193-9.
    View PubMed
  195. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM, Law M, Windschitl HE, Kaur JS, Ellison N. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 1997 Mar; 15(3):969-73.
    View PubMed
  196. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol 1997 Mar; 15(3):1239-43.
    View PubMed
  197. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 1997 Mar; 15(3):1235-8.
    View PubMed
  198. Chong SF, Bretscher ME, Mailliard JA, Tschetter LK, Kimmel DW, Hatfield AK, Loprinzi CL. Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer. J Pain Symptom Manage 1997 Feb; 13(2):112-7.
    View PubMed
  199. Sloan JA, Novotny P, Loprinzi CL, Ghosh M. Graphical and analytical tools for two-period crossover clinical trials. SUGI Proceedings 1997; 22:1312-1317.
  200. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, Wender DB, Burch PA. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. J Clin Oncol (Classic Papers and Current Comments) 1997; 2(1):253-7.
  201. Hammack JE, Mailliard JA, Loprinzi CL, Rospond RM, O'Fallon JR, Wilwerding MB, Reuter NF, Michalak JC, Fidler P, Miser AW. Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage 1996 Oct; 12(4):234-40.
    View PubMed
  202. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996 Sep 1; 36(2):345-9.
    View PubMed
  203. Pisansky TM, Loprinzi CL, Cha SS, Fitzgibbons RJ Jr, Grant CS, Hass AC, Reuter NF, Wold LE, Ingle JN, Kardinal CG. A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinoma. Cancer 1996 Jun 15; 77(12):2520-8.
    View PubMed
  204. Loprinzi CL, Okuno S, Pisansky TM, Sterioff S, Gaffey TA, Morton RF. Postsurgical changes of the breast that mimic inflammatory breast carcinoma. Mayo Clin Proc 1996 Jun; 71(6):552-5.
    View PubMed
  205. Loprinzi CL, Athmann LM, Kardinal CG, O'Fallon JR, See JA, Bruce BK, Dose AM, Miser AW, Kern PS, Tschetter LK, Rayson S. Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology 1996 May-Jun; 53(3):228-32.
    View PubMed
  206. Loprinzi CL, Messing EM, O'Fallon JR, Poon MA, Love RR, Quella SK, Trump DL, Morton RF, Novotny P. Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials. Cancer Epidemiol Biomarkers Prev 1996 May; 5(5):371-4.
    View PubMed
  207. Fidler P, Loprinzi CL, O'Fallon JR, Leitch JM, Lee JK, Hayes DL, Novotny P, Clemens-Schutjer D, Bartel J, Michalak JC. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 1996 Feb 1; 77(3):522-5.
    View PubMed
  208. Rowland KM, Loprinzi CL, Shaw EG, Maksymiuk AW, Kuross SA, Jung SH, Kugler JW, Tschetter LK, Ghosh C, Schaefer PL, Owen D, Washburn JH, Webb TA, Mailliard JA, Jett JR. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate placebo in extensive-stage small-cell lung cancer - a North Central Cancer Treatment Group study. J Clin Oncol 1996 Jan; 14(1):135-141.
    View PubMed
  209. Loprinzi CL. Management of menopausal symptoms in breast cancer survivors. ASCO Spring Educational Book 1996.
  210. Loprinzi CL. North Central Cancer Treatment Group (NCCTG). J Natl Cancer Inst Monogr 1996; 20:79-80.
    View PubMed
  211. Loprinzi CL, Smith TJ. Surveillance testing in curatively-treated cancer survivors. ASCO Educational Book 1996:29-32.
  212. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA 1995 Dec 6; 274(21):1703-5.
    View PubMed
  213. Loprinzi CL, Peethambaram PP. Management of menopausal symptoms in breast cancer patients. Ann Med 1995 Dec; 27(6):653-6.
    View PubMed
  214. Goldberg RM, Loprinzi CL, Mailliard JA, O'Fallon JR, Krook JE, Ghosh C, Hestorff RD, Chong SF, Reuter NF, Shanahan TG. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995 Nov; 13(11):2856-9.
    View PubMed
  215. Loprinzi CL, Foote RL, Michalak J. Alleviation of cytotoxic therapy-induced normal tissue damage. Semin Oncol 1995 Apr; 22(2 Suppl 3):95-7.
    View PubMed
  216. Wilwerding MB, Loprinzi CL, Mailliard JA, O'Fallon JR, Miser AW, Vanhaelst C, Barton DL, Foley JF, Athmann LM. A randomized crossover evaluation of methyphenidate in cancer patients receiving strong narcotics. Support Care Cancer 1995 Mar; 3:135-138.
    View PubMed
  217. Loprinzi CL. Management of cancer anorexia cachexia. Support Care Cancer 1995 Mar; 3:120-122.
    View PubMed
  218. Loprinzi CL. How to manage cancer anorexia/cachexia. Contemporary Oncology Cancer, and HIV-Associated Anorexia and , Evaluation, and Management (Suppl)11-3 1995 Mar; Cachexia:Mechanisms.
  219. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, Bate WW, Rospond RM, Oesterling JE. Megestrol acetate for the prevention of hot flashes. Obstet Gynecol Surv 1995 Feb; 50(2):135-137.
  220. Foote RL, Loprinzi CL, Frank AR, O'Fallon JR, Gulavita S, Tewfik HH, Ryan MA, Earle JM, Novotny P. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 1994 Dec; 12(12):2630-3.
    View PubMed
  221. Quella S, Loprinzi CL, Dose AM. A qualitative approach to defining "hot flashes" in men. Urol Nurs 1994 Dec; 14(4):155-8.
  222. Au E, Loprinzi CL, Dhodapkar M, Nelson T, Novotny P, Hammack J, O'Fallon J. Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity. J Clin Oncol 1994 Dec; 12(12):2751-5.
    View PubMed
  223. Ingle JN, Kuross SA, Mailliard JA, Loprinzi CL, Jung SH, Nelimark RA, Krook JE, Long HJ. Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy. Cancer 1994 Sep 15; 74(6):1733-8.
    View PubMed
  224. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994 Aug 11; 331(6):347-52.
    View PubMed
  225. Loprinzi CL, Wender DB, Veeder MH, O'Fallon JR, Vaught NL, Dose AM, Ghosh C, Bartel J, Leitch JM. Inhibition of 5-fluorouracil-induced ocular irritation by ocular ice packs. Cancer 1994 Aug 1; 74(3):945-8.
    View PubMed
  226. Loprinzi CL, Ravdin PM, de Laurentiis M, Novotny P. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol 1994 Jul; 12(7):1422-6.
    View PubMed
  227. Loprinzi CL, Kuross SA, O'Fallon JR, Gesme DH, Gerstner JB, Rospond RM, Cobau CD, Goldberg RM. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 1994 Jun; 12(6):1121-5.
    View PubMed
  228. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol 1994 Jun; 12(6):1126-9.
    View PubMed
  229. Miser AW, Goh TS, Dose AM, O'Fallon JR, Niedringhaus RD, Betcher DL, Simmons P, MacKellar DJ, Arnold M, Loprinzi CL. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer. J Pain Symptom Manage 1994 May; 9(4):259-64.
    View PubMed
  230. Hammack JE, Loprinzi CL. Use of orally administered opioids for cancer-related pain. Mayo Clin Proc 1994 Apr; 69(4):384-90.
    View PubMed
  231. Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose M. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol 1994 Mar; 151(3):634-6.
    View PubMed
  232. Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, Dose AM, Etzell PS, Nelimark RA, Mailliard JA, Moertel CG. Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 1994 Mar; 12:601-607.
  233. Goldberg RM, Loprinzi CL, O'Fallon JR, Veeder MH, Miser AW, Mailliard JA, Michalak JC, Dose AM, Rowland KM, Burnham NL. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994 Jan; 12(1):155-8.
    View PubMed
  234. Loprinzi CL. Phase III cancer chemoprevention trials: how do they contrast with cancer treatment trials? ASCO Educational Book 1994; 29-33.
  235. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G, Lifsey D, Glaw KC, Stevens BA, Hatfield AK. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 1993 Oct 1; 72(7):2234-8.
    View PubMed
  236. Creagan ET, Schaid DJ, Hartmann LC, Loprinzi CL. A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma. Am J Clin Oncol 1993 Jun; 16(3):243-4.
    View PubMed
  237. Loprinzi CL, Duffy J, Ingle JN. Postchemotherapy rheumatism. J Clin Oncol 1993 Apr; 11(4):768-70.
    View PubMed
  238. Loprinzi CL, Michalak JC, Schaid DJ, Mailliard JA, Athmann LM, Goldberg RM, Tschetter LK, Hatfield AK, Morton RF. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993 Apr; 11(4):762-7.
    View PubMed
  239. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD. Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 1993 Mar 10; 269:1262-1267.
    View PubMed
  240. Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993 Jan; 11(1):152-4.
    View PubMed
  241. Loprinzi CL, O'Fallon JR. Symptom control research in a cooperative oncology group. Advances in Medical Psychotherapy 1993; 6:241-246.
  242. Davis T, Miser AW, Loprinzi CL, Kaur JS, Burnham NL, Dose AM, Ames MM. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer. Hosp J 1993; 9(1):85-90.
    View PubMed
  243. Loprinzi CL. Pharmacologic management of cancer anorexia/cachexia. Oncology 1993; 7:101-103.
  244. Loprinzi CL, Jensen MD, Jiang NS, Schaid DJ. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc 1992 Dec; 67(12):1160-2.
    View PubMed
  245. Pisansky TM, Schaid DJ, Loprinzi CL, Donohue JH, Schray MF, Schomberg PJ. Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol 1992 Oct; 15(5):376-87.
    View PubMed
  246. Loprinzi CL, Goldberg RM, Burnham NL. Cancer-associated anorexia and cachexia. Implications for drug therapy. Drugs 1992 Apr; 43(4):499-506.
    View PubMed
  247. Loprinzi CL, Messing EM. A prospective clinical trial of difluoromethylornithine (DFMO) in patients with resected superficial bladder cancer. J Cell Biochem Suppl 1992; (16I):153-5.
  248. Loprinzi CL, Goldberg RM, Burnham N. Cancer - associated anorexia and cachexia: implications for drug therapy. New Ethicals 1992; 29:125-131.
  249. Loprinzi CL, Johnson PA, Jensen M. Megestrol acetate for anorexia and cachexia. Oncology 1992; 49(Suppl 2):46-9.
    View PubMed
  250. Witzig TE, Loprinzi CL, Gonchoroff NJ, Reiman HM, Cha SS, Wieand HS, Katzmann JA, Paulsen JK, Moertel CG. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages b2 colorectal adenocarcinoma. Cancer 1991 Aug 15; 68:879-888.
    View PubMed
  251. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Goldberg R. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991 Mar;9(3):449-52.
    View PubMed
  252. Ransom DT, Neuberg D, Loprinzi CL, Tormey DC, Blum RH, Harris JE, Asbury RF, Falkson G. A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer. Am J Clin Oncol 1991 Feb; 14(1):45-8.
    View PubMed
  253. Loprinzi CL, Ingle JN, Schaid DJ, Buckner JC, Edmonson JH, Allegra CJ. 5-fluorouracil plus leucovorin in women with metastatic breast cancer. Am J Clin Oncol 1991 Feb; 14:30-32.
    View PubMed
  254. Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gesme DH, Windschitl HE, Pfeifle DM, Etzell PS, Gerstner JG, Long HJ, Foley JF, Loprinzi CL, Dalton RJ. A double-blind trial of tamoxifen plus prednisone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. Cancer 1991; 68:34-39.
    View PubMed
  255. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990 Aug; 8(8):1327-34.
    View PubMed
  256. Kardinal CG, Loprinzi CL, Schaid DJ, Hass AC, Dose AM, Athmann LM, Mailliard JA, McCormack GW, Gerstner JB, Schray MF. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990 Jun 15; 65(12):2657-62.
    View PubMed
  257. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 1990 Apr 15; 65(8):1879-82.
    View PubMed
  258. Loprinzi CL, Love RR, Garrity JA, Ames MM. Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. Cancer Invest 1990; 8(5):459-65.
    View PubMed
  259. Coltman CA, Abrams JS, Aisner J, Cruz JM, Hellerstein MK, Loprinzi CL, Paterson AHG, Schacter LP, Von Roenn JH. Therapy to promote weight gain in cancer and acquired immunodeficiency syndrome patients: a panel discussion (part I). Semin Oncol 1990; 17:34-37.
  260. Loprinzi CL, Dose AM. Studies related to the prevention of 5-fluorouracil-induced oral mucositis. NCI Monogr 1990; 9:93-94.
    View PubMed
  261. Loprinzi CL, Ellison NM, Goldberg RM, Michalak JC, Burch PA. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and North Central Cancer Treatment Group. Semin Oncol 1990; 17:8-12.
    View PubMed
  262. Ames MM, Loprinzi CL, Collins JM, Van Haelst-Pisani CM, Richardson RL, Rubin J, Moertel CG. Phase I and clinical pharmacologic evaluation of pirozantrone hydrochloride (oxantrazole). Cancer Res 1990; 50:3905-3909.
    View PubMed
  263. Loprinzi CL, Ellison NM, Schaid DJ, Krook JE, Athmann LM, Dose AM, Mailliard JA, Johnson PS, Ebbert LP, Geeraerts LH. A controlled trial of megestrol acetate in patients with cancer anorexia and/or cachexia. J Natl Cancer Inst 1990; 82:1127-1132.
    View PubMed
  264. Krook JE, Loprinzi CL, Schaid DJ, Kardinal CG, Mailliard JA, Pfeifle DM, Ellison NM, Reuter NF, Nelimark RA. Evaluation of continuous infusion etoposide plus cisplatin in metastatic breast cancer. A phase II trial. Cancer 1990; 65:418-421.
    View PubMed
  265. Edmonson JH, Buckner JC, Long HJ, Loprinzi CL, Schaid DJ. Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. J Natl Cancer Inst 1989 Jun 7; 81(11):863-6.
    View PubMed
  266. Loprinzi CL, Love RR, Therneau TM, Verman AK. Inhibition of human skin ornithine decarboxylase activity by oral alpha-diflouromethylornithine. Cancer Therapy and Control 1989; 1:75-80.
  267. Loprinzi CL, Rasmussen PW, Tormey DC, Carbone PP. Combined modality treatment of local-regionally advanced breast cancer patients: five to ten year follow up. Am J Clin Oncol 1989; 12:208-212.
    View PubMed
  268. Loprinzi CL. 5FU plus leucovorin in breast cancer. Cancer 1989; 63:1045-1047.
    View PubMed
  269. Gallenberg MM, Loprinzi CL. Breast cancer in pregnancy. Semin Oncol 1989; 16:369-376.
    View PubMed
  270. Loprinzi CL, Burnham NL, O'Connell MJ, Svingen PA, Peterson DA. Allopurinol mouthwash kinetic and stability information based on normal volunteers. Hosp Pharm 1989; 24:353-354.
  271. Creagan ET, Loprinzi CL, Ahmann DL, Schaid DJ. A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. Cancer 1988 Dec 15; 62(12):2472-4.
    View PubMed
  272. Long HJ, Schaid DJ, Schutt AJ, Ingle JN, Loprinzi CL, Edmonson JH. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy. Am J Clin Oncol 1988 Oct; 11(5):524-7.
    View PubMed
  273. Richardson RL, Schutt AJ, O'Connell MJ, Creagan ET, Loprinzi CL, Powis G. Phase I study of amonafide (a) (nsc-308847) given by 24-hour continuous intravenous infusion (24h-civ) every 4 weeks. Proc Annu Meet Am Soc Clin Oncol 1987 Mar; 6:35.
  274. Loprinzi CL, Tormey DC, Rasmussen P, Falkson G, Davis TE, Falkson HC, Chang AY. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. J Clin Oncol 1986 Jan; 4(1):46-56.
    View PubMed
  275. Loprinzi CL, Verma AK. Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity. Carcinogenesis 1985 Nov; 6(11):1589-92.
    View PubMed
  276. Verma AK, Loprinzi CL, Boutwell RK, Carbone PP. In vitro induction of human skin ornithine decarboxylase by the tumor prompter 12-0-tetradecanoylphorbol-13-acetate. J Natl Cancer Inst 1985 Jul; 75:85-90.
    View PubMed
  277. Loprinzi CL, Verma AK, Boutwell RK, Carbone PP. Inhibition of phorbol ester-induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. J Clin Oncol 1985; 3:751-756.
    View PubMed
  278. Loprinzi CL, Verma AK. Studies on the dose and schedule of alpha-difluoromethylornithine needed to inhibit ornithine decarboxylase activity in mice. Cancer Lett 1985; 28:327-333.
    View PubMed
  279. Verma AK, Loprinzi CL, Boutwell RK, Carbone PP. In vitro introduction of human skin ornithine decarboxylase by the tumor promoter 12-0-tetra-decanoylphorbol-13-acetate. J Natl Cancer Inst 1985; 75:85-90.
    View PubMed
  280. Loprinzi CL, Verma AK. Effects of local anesthetics on phorbol ester-induced ornithine decarboxylase activity in mouse and human skin. Anticancer Res 1984 Nov-Dec; 4(6):363-6.
    View PubMed
  281. Trump DL, Loprinzi CL. Phase II trial of etoposide in advanced prostate cancer. Cancer Treat Rep 1984 Sep; 68(9):1195-6.
    View PubMed
  282. Davis TE, Loprinzi CL, Buchler DA. Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary. Gynecol Oncol 1984 Sep; 19(1):46-52.
    View PubMed
  283. Loprinzi CL, Carbone PP, Tormey DC, Rosenbaum PR, Caldwell W, Kline JC, Steeves RA, Ramirez G. Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol 1984 Mar; 2(3):157-63.
    View PubMed
  284. Loprinzi CL. Mitomycin C induced pulmonary and renal toxicity. Wis Med J 1984; 83:16-17.
    View PubMed
  285. Jaffe JP, Loprinzi CL. Basophilic-eosinophilic meningitis in an undifferentiated myeloproliferative disorder. JAMA 1983 Jan 7; 249(1):73-4.
    View PubMed
  286. Loprinzi CL, Heaton JW Jr, Kelly PC. Enterohepatic fistulas associated with amebic liver abscesses. South Med J 1983; 76:384-386.
    View PubMed
  287. Loprinzi CL, Hennessee J, Tamsky L, Johnson TE. Snake antivenom administration in a patient allergic to horse serum. South Med J 1983; 76:501-502.
    View PubMed
  288. Loprinzi CL. Prostatic cancer. South Med J 1982 Feb; 75(2):193-6.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.